Journal of the American Chemical Society
Communication
X. J. Med. Chem. 2010, 53, 5979. (i) Lee, M.; Brockway, O.; Dandavati,
A.; Tzou, S.; Sjoholm, R.; Satam, V.; Westbrook, C.; Mooberry, S. L.;
Zeller, M.; Babu, B.; Lee, M. Eur. J. Med. Chem. 2011, 46, 3099.
(j) Lam, K. W.; Tham, C. L.; Liew, C. Y.; Syahida, A.; Rahman, M. B.
A.; Israf, D. A.; Lajis, N. H. Med. Chem. Res. 2012, 21, 333. (k) Lam, K.
W.; Tham, C. L.; Liew, C. Y.; Syahida, A.; Rahman, M. B. A.; Israf, D.
A.; Lajis, N. H. Med. Chem. Res. 2012, 21, 333.
(2) For selected examples of asymmetric pyrazolines syntheses, see:
́ ̀
(a) Mahe, O.; Dez, I.; Levacher, V.; Briere, J.-F. Angew. Chem., Int. Ed.
2010, 49, 7072. (b) Suga, H.; Furihata, Y.; Sakamoto, A.; Itoh, K.;
Okumura, Y.; Tsuchida, T.; Kakehi, A.; Baba, T. J. Org. Chem. 2011,
76, 7377. (c) Campbell, N. R.; Sun, B.; Singh, R. P.; Deng, L. Adv.
Synth. Catal. 2011, 353, 3123. (d) Chen, J.-R.; Dong, W.-R.; Candy,
M.; Pan, F.-F.; Jorres, M.; Bolm, C. J. Am. Chem. Soc. 2012, 134, 6924.
̈
(e) Zhang, Z.; Wang, D.; Wei, Y.; Shi, M. Chem. Commun. 2012, 48,
́
9607. (f) Fernandez, M.; Reyes, E.; Vicario, J. L.; Badía, D.; Carrillo, L.
Adv. Synth. Catal. 2012, 354, 371. (g) Wang, G.; Liu, X.; Huang, T.;
Kuang, Y.; Lin, L.; Feng, X. Org. Lett. 2013, 15, 76. (h) Tripathi, C. B.;
Mukherjee, S. Org. Lett. 2014, 16, 3368.
(3) For reviews of asymmetric 1,3-dipolar cycloadditions, see:
(a) Gothelf, K. V.; Jørgensen, K. A. Chem. Rev. 1998, 98, 863.
(b) Pellissier, H. Tetrahedron 2007, 63, 3235. (c) Stanley, L. M.; Sibi,
M. P. Chem. Rev. 2008, 108, 2887.
(4) (a) Shintani, R.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 10778.
́
(b) Suarez, A.; Downey, C. W.; Fu, G. C. J. Am. Chem. Soc. 2005, 127,
11244. (c) Arai, T.; Ogino, Y. Molecules 2012, 17, 6170. (d) Imaizumi,
T.; Yamashita, Y.; Kobayashi, S. J. Am. Chem. Soc. 2012, 134, 20049.
(e) Hashimoto, T.; Takiguchi, Y.; Maruoka, K. J. Am. Chem. Soc. 2013,
135, 11473. (f) Arai, T.; Ogino, Y.; Sato, T. Chem. Commun. 2013, 49,
7776.
(5) (a) Ishihara, K.; Fushimi, M. Org. Lett. 2006, 8, 1921. (b) Ishihara,
K.; Fushimi, M.; Akakura, M. Acc. Chem. Res. 2007, 40, 1049.
(c) Ishihara, K.; Fushimi, M. J. Am. Chem. Soc. 2008, 130, 7532.
(d) Sakakura, A.; Hori, M.; Fushimi, M.; Ishihara, K. J. Am. Chem. Soc.
2010, 132, 15550. (e) Sakakura, A.; Ishihara, K. Chem. Soc. Rev. 2011,
40, 163.
(6) For a recent review of π−cation interaction, see: Mahadevi, A. S.;
Sastry, G. N. Chem. Rev. 2013, 113, 2100.
(7) For our contributions to n−cation catalysis, see: Sakakura, A.;
Kondo, R.; Matsumura, Y.; Akakura, M.; Ishihara, K. J. Am. Chem. Soc.
2009, 131, 17762.
(8) MS 4A activated 1·Cu(NTf2)2 and inhibited the hydrolysis of 3.
(9) See Supporting Information for details.
(10) The intramolecular π−cation interaction was observed in the
crystal structure of bis(L-tyrosinato)copper(II) complex. (a) Nasci-
mento, O. R.; Costa-Filho, A. J.; DeMorais, D. I.; Ellena, J.; Delboni, L.
F. Inorg. Chem. Acta 2001, 312, 133. (b) Costa-Filho, A. J.;
Nascimento, O. R.; Calvo, R. J. Phys. Chem. B 2004, 108, 9549.
(11) The spectral evidence for the π−cation interaction between
Cu2+ and tryptophan residue in peptides in aqueous solution was
reported. Yorita, H.; Otomo, K.; Hiramatsu, H.; Toyama, A.; Miura,
T.; Takeuchi, H. J. Am. Chem. Soc. 2008, 130, 15266.
(12) Koptelov, Y. B.; Saik, S. P. Russ. J. Org. Chem. 2006, 42, 1501.
(13) Hernan
Phys. Org. Chem. 2005, 18, 792.
́ ́
dez-Rodríguez, M.; Melgar-Fernandez, R.; Juaristi, E. J.
(14) (a) Takimoto, M.; Kawamura, M.; Mori, M.; Sato, Y. Synlett
2011, 1423. (b) Prashar, D.; Shi, Y.; Bandyopadhyay, D.; Dabrowiak, J.
C.; Luk, Y.-Y. Bioorg. Med. Chem. Lett. 2011, 21, 7421. (c) Teller, H.;
Corbet, M.; Mantilli, L.; Gopakumar, G.; Goddard, R.; Thiel, W.;
Furstner, A. J. Am. Chem. Soc. 2012, 134, 15331.
̈
(15) (a) Casy, G.; Taylor, R. J. K. J. Chem. Soc., Chem. Commun.
1988, 454. (b) Zhang, H.; Reddy, M. S.; Phoenix, S.; Deslongchamps,
P. Angew. Chem., Int. Ed. 2008, 47, 1272.
13201
dx.doi.org/10.1021/ja508441t | J. Am. Chem. Soc. 2014, 136, 13198−13201